WellPoint Price Target Raised to $108.00 at JPMorgan Chase & Co. (WLP)

Share on StockTwits

Stock analysts at JPMorgan Chase & Co. lifted their price target on shares of WellPoint (NYSE:WLP) from $98.00 to $108.00 in a report issued on Monday, Analyst Ratings News reports. JPMorgan Chase & Co.’s price objective suggests a potential upside of 7.86% from the company’s current price.

WellPoint (NYSE:WLP) traded up 0.63% during mid-day trading on Monday, hitting $100.32. 887,369 shares of the company’s stock traded hands. WellPoint has a 52 week low of $64.35 and a 52 week high of $102.56. The stock’s 50-day moving average is $90.80 and its 200-day moving average is $88.87. The company has a market cap of $28.336 billion and a price-to-earnings ratio of 12.17.

WellPoint (NYSE:WLP) last announced its earnings results on Wednesday, January 29th. The company reported $0.87 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.87. The company had revenue of $17.60 billion for the quarter, compared to the consensus estimate of $17.75 billion. During the same quarter in the prior year, the company posted $1.03 earnings per share. The company’s quarterly revenue was up 16.3% on a year-over-year basis. On average, analysts predict that WellPoint will post $8.41 earnings per share for the current fiscal year.

WLP has been the subject of a number of other recent research reports. Analysts at Jefferies Group raised their price target on shares of WellPoint from $102.00 to $117.00 in a research note on Monday. Separately, analysts at Oppenheimer raised their price target on shares of WellPoint from $100.00 to $111.00 in a research note on Monday. They now have an “outperform” rating on the stock. Finally, analysts at Susquehanna raised their price target on shares of WellPoint from $106.00 to $130.00 in a research note on Monday. They now have a “positive” rating on the stock. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $104.82.

WellPoint, Inc (NYSE:WLP) is a health benefit company in terms of medical membership in the United States.

Receive News & Ratings for WellPoint Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WellPoint Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.

Latest News

Washington Real Estate Investment Trust Given Consensus Rating of “Hold” by Brokerages
Washington Real Estate Investment Trust Given Consensus Rating of “Hold” by Brokerages
Qunar Cayman Islands Receives Consensus Rating of “Buy” from Analysts
Qunar Cayman Islands Receives Consensus Rating of “Buy” from Analysts
Neurocrine Biosciences Given Average Rating of “Buy” by Brokerages
Neurocrine Biosciences Given Average Rating of “Buy” by Brokerages
Astoria Financial Corp Given Consensus Recommendation of “Hold” by Analysts
Astoria Financial Corp Given Consensus Recommendation of “Hold” by Analysts
KBR Receives Average Recommendation of “Buy” from Analysts
KBR Receives Average Recommendation of “Buy” from Analysts
Vanguard Natural Resources Given Consensus Recommendation of “Hold” by Analysts
Vanguard Natural Resources Given Consensus Recommendation of “Hold” by Analysts


Leave a Reply

 
Advertisement
Advertisement
© 2006-2014 Mideast Time.